Please assess the completion status of the following clinical trial:

Trial Title: A Study of the Effect on Pain Control of Treatment With Fentanyl, Administered Through the Skin, in Patients With Rheumatoid Arthritis or Osteoarthritis

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patients must meet the American College of Rheumatology criteria for rheumatoid arthritis (RA) or osteoarthritis (OA) of the hip or knee and have moderate or severe pain that is not adequately controlled by other medications (paracetamol (acetaminophen), NSAIDs, COX-2 inhibitors, weak opioids)~* OA patients must be in need of and waiting for hip or knee replacement~* RA patients using disease modifying antirheumatic drugs (DMARDs) must have been on stable dose of medication for \>=3 months.~Exclusion Criteria:~* Patients who have received regular treatment with strong opioids during the month prior to study~* another continuous pain that stands out compared to RA or OA pain~* skin disease or known allergy or hypersensitivity to fentanyl or to the adhesives~* history of liver disease~* new physical therapy or change in that therapy within one month of study~* pregnant or nursing females, or those without adequate contraception.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).